An Initial Evaluation of the Effectiveness of a Dietary Supplement Regimen on the Effects of Post-COVID Infection |Biomedgrid

The prevalence of COVID-19 (Coronavirus) infection has been categorized as pandemic since November 2019. Currently the pandemic is slowdown, but now the prolonged COVID amid other derived medical conditions are emerging. The identification of Coronavirus infection by various assessments is well-known including initial diagnosis by symptoms. Some of the symptoms have been seen to persist beyond the normal incubation time and some additional symptoms have arisen to be termed as post-COVID-19 or Long COVID which include loss of energy, memory issues, persistence of pain and sleeplessness. In this study, 15 randomized adult post-COVID infection participants were evaluated with a 3-day control followed by a 5-day Electrocide® treatment protocol. All the participants noted a significant increase in energy. 88% of the participants noted a significant decrease in pain. 75% of the participants noted a significant improvement in sleep. As in our previous studies [1], the elimination of active COVID-19 infection (diagnosed by fever, coughing, runny nose, brain fog, headache, and pain) can be achieved in an average of 6 days with the use of Electrocide®. The current study furthermore demonstrates the effectiveness of the Electrocide® as a 7-day treatment for post-COVID infection. A specially formulated enzyme formula added to the Electrocide® regime was also evaluated against a placebo control and it was found that there was rapid recovery from a number of symptoms associated with long haul, chronic COVID-19 as well as vaccine effects including peripheral neuropathy, eye blurriness, and heart issues. The current study furthermore demonstrates the effectiveness of the Electrocide® and enzyme formula as a 7-day treatment for many of the symptoms of COVID-19, COVID-19 vaccine, and COVID-19 long haul.